Prognostic impact of neoadjuvant aglepristone treatment in clinicopathological parameters of progesterone receptor-positive canine mammary carcinomas

SILVIA GUIL LUNAMARIA YOLANDA MILLÁN RUIZ2026-01-292026-01-29201710.1111/vco.121752-s2.0-84955072074https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/26720Veterinary (all)Prognostic impact of neoadjuvant aglepristone treatment in clinicopathological parameters of progesterone receptor-positive canine mammary carcinomasresearch article